SUBSCRIBE TO OUR FREE NEWSLETTER
Daily news & progressive opinion—funded by the people, not the corporations—delivered straight to your inbox.
5
#000000
#FFFFFF
5
#000000
#FFFFFF
On World AIDS Day, Warnings of TPP's "Real Threat" to Medication Access
'Our trade deals should put people before profits, but TPP would do just the opposite.'
Dec 01, 2015
The Trans-Pacific Partnership (TPP), a controversial 12-nation deal that critics warn favors corporate power over public health, specifically threatens access to essential drugs for people with HIV and AIDS, an advocacy group warned Tuesday marking World AIDS Day.
"By harming access to live-saving medications, the TPP poses a real threat to our continued progress in fighting the pandemic," said Jerame Davis, executive director of Pride at Work, an AFL-CIO subsidiary that organizes support for labor and LGBTQI issues. "Continued worldwide progress in containing and fighting back against HIV/AIDS means access to affordable drugs."
Provisions in the TPP would allow, among other things, extended patents on biologics that would grant Big Pharma free rein to ratchet up prices on what Pride at Work calls "the most effective" HIV/AIDS medications.
As economist Dean Baker recently explained, "Patent monopolies provide both enormous incentive and opportunity for drug companies to increase profits at the expense of patients."
Such monopolistic protections for drug manufacturers--which already exist to some extent and would only be expanded through the so-called trade deal--"would have a dramatic effect on access to safe and affordable care for millions of people worldwide," Pride at Work said Tuesday.
International aid agency Oxfam in May warned that the TPP would "do more to undermine access to affordable medicines than any previous U.S. trade agreement" and that the agreement's intellectual property provisions "are incoherent and inconsistent with U.S. global health policy."
In one example, Oxfam found that under the TPP's rules, more than half of HIV/AIDS patients in Vietnam would lose access to vital medication. There are over 250,000 people living with those viruses in Vietnam alone.
"World AIDS Day is an annual chance to reflect on our battle against the HIV/AIDS pandemic and a reminder that we have an obligation to care for each other," Davis said Tuesday. "Treatment of those living with the virus is needed not only to save the lives those living with HIV/AIDS, but to prevent new infections as well--those who have access to treatment are less likely to pass on the virus. Our trade deals should put people before profits, but TPP would do just the opposite."
An Urgent Message From Our Co-Founder
Dear Common Dreams reader, It’s been nearly 30 years since I co-founded Common Dreams with my late wife, Lina Newhouser. We had the radical notion that journalism should serve the public good, not corporate profits. It was clear to us from the outset what it would take to build such a project. No paid advertisements. No corporate sponsors. No millionaire publisher telling us what to think or do. Many people said we wouldn't last a year, but we proved those doubters wrong. Together with a tremendous team of journalists and dedicated staff, we built an independent media outlet free from the constraints of profits and corporate control. Our mission has always been simple: To inform. To inspire. To ignite change for the common good. Building Common Dreams was not easy. Our survival was never guaranteed. When you take on the most powerful forces—Wall Street greed, fossil fuel industry destruction, Big Tech lobbyists, and uber-rich oligarchs who have spent billions upon billions rigging the economy and democracy in their favor—the only bulwark you have is supporters who believe in your work. But here’s the urgent message from me today. It's never been this bad out there. And it's never been this hard to keep us going. At the very moment Common Dreams is most needed, the threats we face are intensifying. We need your support now more than ever. We don't accept corporate advertising and never will. We don't have a paywall because we don't think people should be blocked from critical news based on their ability to pay. Everything we do is funded by the donations of readers like you. When everyone does the little they can afford, we are strong. But if that support retreats or dries up, so do we. Will you donate now to make sure Common Dreams not only survives but thrives? —Craig Brown, Co-founder |
Our work is licensed under Creative Commons (CC BY-NC-ND 3.0). Feel free to republish and share widely.
Nadia Prupis
Nadia Prupis is a former Common Dreams staff writer. She wrote on media policy for Truthout.org and has been published in New America Media and AlterNet. She graduated from UC Santa Barbara with a BA in English in 2008.
The Trans-Pacific Partnership (TPP), a controversial 12-nation deal that critics warn favors corporate power over public health, specifically threatens access to essential drugs for people with HIV and AIDS, an advocacy group warned Tuesday marking World AIDS Day.
"By harming access to live-saving medications, the TPP poses a real threat to our continued progress in fighting the pandemic," said Jerame Davis, executive director of Pride at Work, an AFL-CIO subsidiary that organizes support for labor and LGBTQI issues. "Continued worldwide progress in containing and fighting back against HIV/AIDS means access to affordable drugs."
Provisions in the TPP would allow, among other things, extended patents on biologics that would grant Big Pharma free rein to ratchet up prices on what Pride at Work calls "the most effective" HIV/AIDS medications.
As economist Dean Baker recently explained, "Patent monopolies provide both enormous incentive and opportunity for drug companies to increase profits at the expense of patients."
Such monopolistic protections for drug manufacturers--which already exist to some extent and would only be expanded through the so-called trade deal--"would have a dramatic effect on access to safe and affordable care for millions of people worldwide," Pride at Work said Tuesday.
International aid agency Oxfam in May warned that the TPP would "do more to undermine access to affordable medicines than any previous U.S. trade agreement" and that the agreement's intellectual property provisions "are incoherent and inconsistent with U.S. global health policy."
In one example, Oxfam found that under the TPP's rules, more than half of HIV/AIDS patients in Vietnam would lose access to vital medication. There are over 250,000 people living with those viruses in Vietnam alone.
"World AIDS Day is an annual chance to reflect on our battle against the HIV/AIDS pandemic and a reminder that we have an obligation to care for each other," Davis said Tuesday. "Treatment of those living with the virus is needed not only to save the lives those living with HIV/AIDS, but to prevent new infections as well--those who have access to treatment are less likely to pass on the virus. Our trade deals should put people before profits, but TPP would do just the opposite."
Nadia Prupis
Nadia Prupis is a former Common Dreams staff writer. She wrote on media policy for Truthout.org and has been published in New America Media and AlterNet. She graduated from UC Santa Barbara with a BA in English in 2008.
The Trans-Pacific Partnership (TPP), a controversial 12-nation deal that critics warn favors corporate power over public health, specifically threatens access to essential drugs for people with HIV and AIDS, an advocacy group warned Tuesday marking World AIDS Day.
"By harming access to live-saving medications, the TPP poses a real threat to our continued progress in fighting the pandemic," said Jerame Davis, executive director of Pride at Work, an AFL-CIO subsidiary that organizes support for labor and LGBTQI issues. "Continued worldwide progress in containing and fighting back against HIV/AIDS means access to affordable drugs."
Provisions in the TPP would allow, among other things, extended patents on biologics that would grant Big Pharma free rein to ratchet up prices on what Pride at Work calls "the most effective" HIV/AIDS medications.
As economist Dean Baker recently explained, "Patent monopolies provide both enormous incentive and opportunity for drug companies to increase profits at the expense of patients."
Such monopolistic protections for drug manufacturers--which already exist to some extent and would only be expanded through the so-called trade deal--"would have a dramatic effect on access to safe and affordable care for millions of people worldwide," Pride at Work said Tuesday.
International aid agency Oxfam in May warned that the TPP would "do more to undermine access to affordable medicines than any previous U.S. trade agreement" and that the agreement's intellectual property provisions "are incoherent and inconsistent with U.S. global health policy."
In one example, Oxfam found that under the TPP's rules, more than half of HIV/AIDS patients in Vietnam would lose access to vital medication. There are over 250,000 people living with those viruses in Vietnam alone.
"World AIDS Day is an annual chance to reflect on our battle against the HIV/AIDS pandemic and a reminder that we have an obligation to care for each other," Davis said Tuesday. "Treatment of those living with the virus is needed not only to save the lives those living with HIV/AIDS, but to prevent new infections as well--those who have access to treatment are less likely to pass on the virus. Our trade deals should put people before profits, but TPP would do just the opposite."
We've had enough. The 1% own and operate the corporate media. They are doing everything they can to defend the status quo, squash dissent and protect the wealthy and the powerful. The Common Dreams media model is different. We cover the news that matters to the 99%. Our mission? To inform. To inspire. To ignite change for the common good. How? Nonprofit. Independent. Reader-supported. Free to read. Free to republish. Free to share. With no advertising. No paywalls. No selling of your data. Thousands of small donations fund our newsroom and allow us to continue publishing. Can you chip in? We can't do it without you. Thank you.